Gary Maartens (G Maartens)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 80

Top Venues

Antimicrobial agents and chemotherapy

Southern African journal of HIV medicine

British journal of clinical pharmacology

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

University of Cape Town

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cape Town Apr 01 2004

South Africa

Professor of Clinical Pharmacology :: Medicine

Publications

Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens, Graeme Meintjes
Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART. Southern African journal of HIV medicine 25 (1) (2024)
Ying Zhao, Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens, Graeme Meintjes
Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART. Southern African journal of HIV medicine 25 (1) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Yann Ruffieux, Nathalie Verónica Fernández Villalobos, Christiane Didden, Andreas D Haas, Chido Chinogurei, Morna Cornell, Matthias Egger, Gary Maartens, Naomi Folb, Eliane Rohner
Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Yann Ruffieux, Nathalie Verónica Fernández Villalobos, Christiane Didden, Andreas D Haas, Chido Chinogurei, Morna Cornell, Matthias Egger, Gary Maartens, Naomi Folb, Eliane Rohner
Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Yann Ruffieux, Nathalie Verónica Fernández Villalobos, Christiane Didden, Andreas D Haas, Chido Chinogurei, Morna Cornell, Matthias Egger, Gary Maartens, Naomi Folb, Eliane Rohner
Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology (2024)
Yann Ruffieux, Nathalie Verónica Fernández Villalobos, Christiane Didden, Andreas D Haas, Chido Chinogurei, Morna Cornell, Matthias Egger, Gary Maartens, Naomi Folb, Eliane Rohner
Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Clifford George Banda, Dumisile Nkosi, Elizabeth Allen, Lesley Workman, Mwayiwawo Madanitsa, Marumbo Chirwa, Mayamiko Kapulula, Sharon Muyaya, Steven Munharo, Joel Tarning, Kamija S Phiri, Victor Mwapasa, Feiko O Ter Kuile, Gary Maartens, Karen I Barnes
Erratum for Banda et al., "Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV". Antimicrobial agents and chemotherapy 67 (1) (2023)
Clifford George Banda, Dumisile Nkosi, Elizabeth Allen, Lesley Workman, Mwayiwawo Madanitsa, Marumbo Chirwa, Mayamiko Kapulula, Sharon Muyaya, Steven Munharo, Joel Tarning, Kamija S Phiri, Victor Mwapasa, Feiko O Ter Kuile, Gary Maartens, Karen I Barnes
Erratum for Banda et al., "Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV". Antimicrobial agents and chemotherapy 67 (1) (2023)
Ying Zhao, Rulan Griesel, Zaayid Omar, Bryony Simmons, Andrew Hill, Gert U van Zyl, Claire Keene, Gary Maartens, Graeme Meintjes
Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a non-comparative, double-blind, randomised placebo-controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Caryn M Upton, Lubbe Wiesner, Kelly E Dooley, Gary Maartens
Cerebrospinal Fluid and Tuberculosis Meningitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Dan Carr, Gary Maartens, Daniel F Carr, Christopher Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomised controlled trial of N-acetylcysteine for treatment of anti-tuberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Kamunkhwala Gausi, Henry Mugerwa, Marco Siccardi, Maiara Camotti Montanha, Mohammed Lamorde, Lubbe Wiesner, Antonio D'Avolio, Helen McIlleron, Ed Wilkins, Amedeo De Nicolò, Gary Maartens, Saye Khoo, Cissy Kityo, Paolo Denti, Catriona Waitt
Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Clifford George Banda, Dumisile Nkosi, Elizabeth Allen, Lesley Workman, Mwayiwawo Madanitsa, Marumbo Chirwa, Mayamiko Kapulula, Sharon Muyaya, Steven Munharo, Joel Tarning, Kamija S Phiri, Victor Mwapasa, Feiko O Ter Kuile, Gary Maartens, Karen I Barnes
Erratum for Banda et al., "Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV". Antimicrobial agents and chemotherapy 67 (1) (2023)
Gary Maartens, Phumla Z Sinxadi, Willem Daniel Francois Venter
Weight gain on dolutegravir: Association is not the same as causation. Southern African journal of HIV medicine 24 (1) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Yann Ruffieux, Anja Wettstein, Gary Maartens, Naomi Folb, Cristina Mesa Vieira, Christiane Didden, Mpho Tlali, Chanwyn Williams, Morna Cornell, Michael Schomaker, Leigh F Johnson, John A Joska, Matthias Egger, Andreas D Haas
Life-years lost associated with mental illness: a cohort study of beneficiaries of a South African medical insurance scheme. medRxiv : the preprint server for health sciences (2023)
Yann Ruffieux, Anja Wettstein, Gary Maartens, Naomi Folb, Cristina Mesa Vieira, Christiane Didden, Mpho Tlali, Chanwyn Williams, Morna Cornell, Michael Schomaker, Leigh F Johnson, John A Joska, Matthias Egger, Andreas D Haas
Life-years lost associated with mental illness: a cohort study of beneficiaries of a South African medical insurance scheme. medRxiv : the preprint server for health sciences (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy (2023)
Clifford George Banda, Dumisile Nkosi, Elizabeth Allen, Lesley Workman, Mwayiwawo Madanitsa, Marumbo Chirwa, Mayamiko Kapulula, Sharon Muyaya, Steven Munharo, Joel Tarning, Kamija S Phiri, Victor Mwapasa, Feiko O Ter Kuile, Gary Maartens, Karen I Barnes
Erratum for Banda et al., "Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV". Antimicrobial agents and chemotherapy (2023)
Ying Zhao, Rulan Griesel, Zaayid Omar, Bryony Simmons, Andrew Hill, Gert U van Zyl, Claire Keene, Gary Maartens, Graeme Meintjes
Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a non-comparative, double-blind, randomised placebo-controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Yann Ruffieux, Anja Wettstein, Gary Maartens, Naomi Folb, Cristina Mesa Vieira, Christiane Didden, Mpho Tlali, Chanwyn Williams, Morna Cornell, Michael Schomaker, Leigh F Johnson, John A Joska, Matthias Egger, Andreas D Haas
Life-years lost associated with mental illness: a cohort study of beneficiaries of a South African medical insurance scheme. medRxiv : the preprint server for health sciences (2023)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Phumla Z Sinxadi, Simiso Mandisa Sokhela, Nomathemba C Chandiwana, Willem Daniel Francois Venter, Lubbe Wiesner, Gary Maartens, Paolo Denti
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population. CPT: pharmacometrics & systems pharmacology (2023)
Yann Ruffieux, Anja Wettstein, Gary Maartens, Naomi Folb, Cristina Mesa Vieira, Christiane Didden, Mpho Tlali, Chanwyn Williams, Morna Cornell, Michael Schomaker, Leigh F Johnson, John A Joska, Matthias Egger, Andreas D Haas
Life-years lost associated with mental illness: a cohort study of beneficiaries of a South African medical insurance scheme. medRxiv : the preprint server for health sciences (2023)
Rulan Griesel, Gary Maartens, Maxwell Chirehwa, Simiso Sokhela, Godspower Akpomiemie, Michelle Moorhouse, Francois Venter, Phumla Sinxadi
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (11) (2022)
Jani van der Hoven, Elizabeth Allen, Annibale Cois, Reneé De Waal, Gary Maartens, Landon Myer, Thokozile R Malaba, Hlengiwe Madlala, Dorothy Nyemba, Florence Phelanyane, Andrew Boulle, Ushma Mehta, Emma Kalk
Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment. BMC pregnancy and childbirth 22 (1) (2022)
Angharad G Davis, Sean Wasserman, Cari Stek, Mpumi Maxebengula, C Jason Liang, Stephani Stegmann, Sonya Koekemoer, Amanda Jackson, Yakub Kadernani, Marise Bremer, Remy Daroowala, Saalikha Aziz, Rene Goliath, Louise Lai Sai, Thandi Sihoyiya, Paolo Denti, Rachel Pj Lai, Thomas Crede, Jonathan Naude, Patryk Szymanski, Yakoob Vallie, Ismail Abbas Banderker, Muhammed S Moosa, Peter Raubenheimer, Sally Candy, Curtis Offiah, Gerda Wahl, Isak Vorster, Gary Maartens, John Black, Graeme Meintjes, Robert J Wilkinson
A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Zinhle Cindi, Aida N Kawuma, Gary Maartens, Yuki Bradford, Francois Venter, Simiso Sokhela, Nomathemba Chandiwana, Roeland E Wasmann, Paolo Denti, Lubbe Wiesner, Marylyn D Ritchie, David W Haas, Phumla Z Sinxadi
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus. The Journal of infectious diseases 226 (9) (2022)
Clifford George Banda, Dumisile Nkosi, Elizabeth Allen, Lesley Workman, Mwayiwawo Madanitsa, Marumbo Chirwa, Mayamiko Kapulula, Sharon Muyaya, Steven Munharo, Joel Tarning, Kamija S Phiri, Victor Mwapasa, Feiko O Ter Kuile, Gary Maartens, Karen I Barnes
Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV. Antimicrobial agents and chemotherapy (2022)
Stijn W van Beek, Lénaïg Tanneau, Graeme Meintjes, Sean Wasserman, Neel R Gandhi, Angie Campbell, Charle A Viljoen, Lubbe Wiesner, Rob E Aarnoutse, Gary Maartens, James C M Brust, Elin M Svensson
Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment. Open forum infectious diseases 9 (8) (2022)
Enkosi Mondleki, Clifford George Banda, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Lubbe Wiesner, Willem Daniel Francois Venter, Gary Maartens, Phumla Z Sinxadi
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV. Southern African journal of HIV medicine 23 (1) (2022)
Rulan Griesel, Aida N Kawuma, Roeland E Wasmann, Simiso Sokhela, Godspower Akpomiemie, W D Francois Venter, Lubbe Wiesner, Paolo Denti, Phumla Sinxadi, Gary Maartens
Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy. British journal of clinical pharmacology 88 (3) (2022)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Kelly E Dooley, Marta Boffito, Gary Maartens, Paolo Denti
Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with Rifampicin. Antimicrobial agents and chemotherapy 66 (6) (2022)
Enkosi Mondleki, Clifford George Banda, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Lubbe Wiesner, Willem Daniel Francois Venter, Gary Maartens, Phumla Z Sinxadi
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV. Southern African journal of HIV medicine 23 (1) (2022)
Amedeo De Nicolò, Andrea Calcagno, Ilaria Motta, Elisa De Vivo, Antonio D'Avolio, Giovanni Di Perri, Lubbe Wiesner, Isma-Eel Ebrahim, Gary Maartens, Catherine Orrell, Helen M McIlleron
The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study. Antimicrobial agents and chemotherapy 66 (6) (2022)
David W Haas, Mahmoud Tareq Abdelwahab, Stijn W van Beek, Paxton Baker, Gary Maartens, Yuki Bradford, Marylyn D Ritchie, Sean Wasserman, Graeme Meintjes, Karen Beeri, Neel R Gandhi, Elin M Svensson, Paolo Denti, James C M Brust
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa. The Journal of infectious diseases 226 (1) (2022)
Simon E Koele, Stijn W van Beek, Gary Maartens, James C M Brust, Elin M Svensson
Optimized Loading Dose Strategies for Bedaquiline When Restarting Interrupted Drug-Resistant Tuberculosis Treatment. Antimicrobial agents and chemotherapy 66 (3) (2022)
Clifford George Banda, Dumisile Nkosi, Elizabeth Allen, Lesley Workman, Mwayiwawo Madanitsa, Marumbo Chirwa, Mayamiko Kapulula, Sharon Muyaya, Steven Munharo, Lubbe Wiesner, Kamija S Phiri, Victor Mwapasa, Feiko O Ter Kuile, Gary Maartens, Karen I Barnes
Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV. The Journal of antimicrobial chemotherapy 77 (6) (2022)
Richard Court, Kamunkhwala Gausi, Buyisile Mkhize, Lubbe Wiesner, Catriona Waitt, Helen M McIlleron, Gary Maartens, Paolo Denti, Marian Loveday
Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis. British journal of clinical pharmacology 88 (8) (2022)
Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, Shaazia Allie, Mohamed Farouk Chughlay, Mashiko Setshedi, Sean Wasserman, David F Stead, Karen Cohen
Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort. Southern African journal of HIV medicine 23 (1) (2022)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Kelly E Dooley, Gary Maartens, Paolo Denti
Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model. British journal of clinical pharmacology (2022)
Nicola Gawler, Steven J Reynolds, Nei-Yuan Hsiao, William Clarke, Gary Maartens, Elaine J Abrams, Landon Myer, Andrew D Redd, Tamsin K Phillips
Routine Antiretroviral Pharmacy Refill Information Can Predict Failure Postpartum in Previously Suppressed South African Women With HIV. Open forum infectious diseases 9 (10) (2022)
Rulan Griesel, Phumla Sinxadi, Aida Kawuma, John Joska, Simiso Mandisa Sokhela, Godspower Akpomiemie, Willem Daniel Francois Venter, Paolo Denti, David W Haas, Gary Maartens
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population. The Journal of antimicrobial chemotherapy 77 (11) (2022)
Caryn M Upton, Chanel I Steele, Gary Maartens, Andreas H Diacon, Lubbe Wiesner, Kelly E Dooley
Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB). The Journal of antimicrobial chemotherapy 77 (6) (2022)
Ying Zhao, Gary Maartens, Graeme Meintjes
Dolutegravir for second-line treatment: Programmatic implications of new evidence. Southern African journal of HIV medicine 23 (1) (2022)
Daniël Jacobus van Hoving, Graeme Meintjes, Gary Maartens, Andre Pascal Kengne
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre. Wellcome open research 5 (2022)
Noha Abdelgawad, Maxwell Chirehwa, Charlotte Schutz, David Barr, Amy Ward, Saskia Janssen, Rosie Burton, Robert John Wilkinson, Muki Shehu Shey, Lubbe Wiesner, Helen M McIlleron, Gary Maartens, Graeme Meintjes, Paolo Denti
A comparison of the population pharmacokinetics of rifampicin, isoniazid and pyrazinamide between hospitalized and non-hospitalized tuberculosis patients with or without HIV. Wellcome open research 7 (2022)
Precious Ngwalero, James C M Brust, Stijn W van Beek, Sean Wasserman, Gary Maartens, Graeme Meintjes, Anton Joubert, Jennifer Norman, Sandra Castel, Neel R Gandhi, Paolo Denti, Helen M McIlleron, Elin M Svensson, Lubbe Wiesner
Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 65 (11) (2021)
Rulan Griesel, Andrew Hill, Graeme Meintjes, Gary Maartens
Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial. Wellcome open research 6 (2021)
Mahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, Keertan Dheda, Lubbe Wiesner, Neel R Gandhi, Robin M Warren, Frederick A Sirgel, Graeme Meintjes, Gary Maartens, Paolo Denti
Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 65 (12) (2021)
Ying Zhao, Claire Keene, Rulan Griesel, Kaneez Sayed, Zimasa Gcwabe, Amanda Jackson, Olina Ngwenya, Charlotte Schutz, Rene Goliath, Tali Cassidy, Eric Goemaere, Andrew Hill, Gary Maartens, Graeme Meintjes
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial. Wellcome open research 6 (2021)
Eric H Decloedt, Phumla Z Sinxadi, Lubbe Wiesner, John A Joska, David W Haas, Gary Maartens
Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid. Southern African journal of HIV medicine 22 (1) (2021)
Maxwell Tawanda Chirehwa, Richard Court, Mariana de Kock, Lubbe Wiesner, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Gary Maartens, Rob Warren, Paolo Denti, Helen M McIlleron
Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy 65 (10) (2021)
Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, Cari Stek, Marise Bremer, Remy Daroowala, Saalikha Aziz, Rene Goliath, Stephani Stegmann, Sonya Koekemoer, Amanda Jackson, Louise Lai Sai, Yakub Kadernani, Thandi Sihoyiya, C Jason Liang, Lori Dodd, Paolo Denti, Thomas Crede, Jonathan Naude, Patryk Szymanski, Yakoob Vallie, Ismail Banderker, Shiraz Moosa, Peter Johann Raubenheimer, Rachel P J Lai, John Joska, Sam Nightingale, Anna J Dreyer, Gerda Wahl, Curtis Offiah, Isak Vorster, Sally Candy, Frances Robertson, Ernesta Meintjes, Gary Maartens, John M Black, Graeme Meintjes, Robert John Wilkinson
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]. Wellcome open research 6 (2021)
Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, Shaazia Allie, Mohamed F Chughlay, Mashiko Setshedi, Sean Wasserman, David F Stead, Nicole Hickman, Annemie Stewart, Mark Sonderup, Catherine Wendy Spearman, Karen Cohen
A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (9) (2021)
Maxwell Tawanda Chirehwa, Richard Court, Mariana de Kock, Lubbe Wiesner, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Gary Maartens, Rob Warren, Paolo Denti, Helen M McIlleron
Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone. Antimicrobial agents and chemotherapy 64 (11) (2020)
Kairoonisha Mahomed, Carole L Wallis, Liezl Dunn, Shavani Maharaj, Gary Maartens, Graeme Meintjes
Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy. Southern African journal of HIV medicine 21 (1) (2020)
Daniël Jacobus van Hoving, Graeme Meintjes, Gary Maartens, Andre Pascal Kengne
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre. Wellcome open research 5 (2020)
Tom H Boyles, Matilda Nduna, Thalitha Pitsi, Lesley Scott, Matthew P Fox, Gary Maartens
A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV. Open forum infectious diseases 7 (2) (2020)
Gary Maartens
'Covering the tail' after stopping efavirenz-based antiretroviral therapy. Southern African journal of HIV medicine 21 (1) (2020)
Sean Wasserman, Shu Huo, Karina Ky, Ysabella Noelle Malig, Ali Esmail, Keertan Dheda, Peter Bacchetti, Roy Gerona, Gary Maartens, Monica Gandhi, John Metcalfe
Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 64 (3) (2020)
Katherine Antel, Vernon Johan Louw, Gary Maartens, Jenna Oosthuizen, Estelle Verburgh
Diagnosing lymphoma in the shadow of an epidemic: lessons learned from the diagnostic challenges posed by the dual tuberculosis and HIV epidemics. Leukemia & lymphoma 61 (14) (2020)
Jeremy S Nel, Sipho K Dlamini, Graeme Meintjes, Rosie Burton, John M Black, Natasha E C G Davies, Eric Hefer, Gary Maartens, Phetho M Mangena, Moeketsi T Mathe, Mahomed-Yunus S Moosa, Muhangwi B Mulaudzi, Michelle A Moorhouse, Jennifer Nash, Thandekile C Manzini, Wolfgang Preiser, Mohammed S Rassool, David F Stead, Helen van der Plas, Cloete van Vuuren, Willem Daniel Francois Venter, Joana F Woods
Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update. Southern African journal of HIV medicine 21 (1) (2020)
Nazanin Ghafari, Richard Court, Maxwell Tawanda Chirehwa, Lubbe Wiesner, Lucretia Petersen, Gary Maartens, Tawanda Gumbo, Helen McIlleron, Lebogang Ramma
Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis. International journal of audiology 59 (3) (2019)
Jenna Johnston, Lubbe Wiesner, Peter Smith, Gary Maartens, Catherine Orrell
Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans. Southern African journal of HIV medicine 20 (1) (2019)
Karen Cohen, Gary Maartens
A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis. Expert opinion on drug safety 18 (10) (2019)
Clifford George Banda, Karen I Barnes, Gary Maartens
Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine. Antimicrobial agents and chemotherapy 63 (6) (2019)
Douglas P K Wilson, Mahomed-Yunus S Moosa, Ted Cohen, Patrick Cudahy, Colleen Aldous, Gary Maartens
Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements. Open forum infectious diseases 5 (11) (2018)
Fiona Mendelson, Rulan Griesel, Nicki Tiffin, Molebogeng Rangaka, Andrew Boulle, Marc Mendelson, Gary Maartens
C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study. BMC infectious diseases 18 (1) (2018)
Gary Maartens, Annemie Stewart, Rulan Griesel, Andre Pascal Kengne, Felix Dube, Mark P Nicol, Molebogeng X Rangaka, Marc Mendelson
Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization's algorithm for seriously ill HIV-infected patients. Southern African journal of HIV medicine 19 (1) (2018)
Cari Stek, Charlotte Schutz, Lisette Blumenthal, Friedrich Thienemann, Jozefien Buyze, Christiana Nöstlinger, Raffaella Ravinetto, Edwin Wouters, Robert Colebunders, Gary Maartens, Robert John Wilkinson, Lutgarde Lynen, Graeme Meintjes
Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial). JMIR research protocols 5 (3) (2016)
Johannes P Mouton, Karen Cohen, Gary Maartens
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen. Expert review of clinical pharmacology 9 (11) (2016)

Gary Maartens.css-eqlu8i{font-size:small;padding-left:4px;} (G Maartens)

Publication Activity (10 Years)

Top Topics

Top Venues

Gary Maartens (G Maartens)